CDC updates clinical guidance on treating COVID-19 recurrence after antiviral pill

May 24, 2022 - 02:49 PM
Coronavirus Update 900x400

The Centers for Disease Control and Prevention today released updated guidance for clinicians treating COVID-19 in patients who received the Pfizer COVID-19 antiviral pill Paxlovid. 

“There is currently no evidence that additional treatment is needed with Paxlovid or other anti-SARS-CoV-2 therapies in cases where COVID-19 rebound is suspected,” CDC said, noting that a brief return of symptoms may be part of the natural history of SARS-CoV-2 infection in some individuals, “independent of treatment with Paxlovid and regardless of vaccination status.”

CDC continues to recommend Paxlovid to treat mild to moderate COVID-19 in patients at high risk for progressing to severe disease and isolating patients when COVID-19 rebounds to manage transmission risk.

Related News Articles

#HealthCareInnovation Blog
A Strategy to Tackle Public Health Misinformation
In the fall of 2021, two years into the COVID-19 pandemic in the U.S., nearly 80% of adults said they had heard “at least one of eight different false…
Headline
Newest AHA COVID-19 vaccination digital toolkit seeks to beat the summertime blues
Summertime is right around the corner and AHA’s new social media toolkit promotes COVID-19 vaccination and boosters as a means for keeping kids active and…
Headline
FDA authorizes 4th Pfizer COVID-19 bivalent dose for certain children under 5
The Food and Drug Administration April 28 authorized a fourth Pfizer COVID-19 bivalent vaccine dose at least one month after the third dose for certain…
Headline
CDC: Monovalent vaccination was 76% effective at preventing mechanical ventilation, death in hospitalized COVID-19 patients during omicron
In a study of adults hospitalized between February 2022 and February 2023, when the omicron variant predominated, monovalent mRNA vaccination was 76%…
Headline
CDC recommends second COVID-19 bivalent booster for older adults, immunocompromised 
The Centers for Disease Control and Prevention April 19 recommended a second Moderna or Pfizer COVID-19 bivalent vaccine dose for adults aged 65 and older…
Headline
HHS announces plan to support continued access to COVID-19 vaccines, treatments for uninsured
The Department of Health and Human Services on April 19 announced a $1.1 billion public-private partnership to help maintain access to COVID-19…